Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Who wants a pig organ? Patients sick and tired of waiting years for a transplant

People worried they'll never get a scarce human transplant want to know when they might get a pig kidney instead

The Independent UK

Alabama Woman Receives Successful Pig Kidney Transplant

Alabama woman's successful pig kidney transplant showcases potential of xenotransplantation in revolutionizing organ transplantation.

Top News

An Alabama woman is doing well after the latest experimental pig kidney transplant

An Alabama woman received a pig kidney transplant last month and is free from dialysis for the first time eight years

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

2 "Strong Buy"-Rated Biotech Stocks With 303% to 446% Upside Potential

While the upside is appealing, penny stocks carry some risks.

Barchart

Is Exelixis Positioned to Capitalize on Emerging Cancer Therapies?

In the expanding oncology market, Exelixis (EXEL) is gaining attention with its strong pipeline and impressive stock performance. With a clear focus on cancer treatment innovation and a growing market presence, is the company set to lead the future of cancer care and treatment? Read more….

StockNews.com

Illegal Distribution of Unapproved Botulinum Toxin Products Raises Concerns Amid K-Beauty Boom

The illegal sale of unapproved Korean botulinum toxin products raises serious health concerns amid the K-beauty boom.

International Business Times UK

Pediatric RSV vaccine trial paused by Moderna amid safety concerns

Five infants required hospitalization, with one needing mechanical ventilation.

Fortune

Read news from The Economist, FT, and more,
with one subscription

The biohackers who make DIY insulin

Why pay $84,000 for a hepatitis C drug when you can make it at home? But such DIY chemistry raises safety concerns

Salon

Trump nominees should ‘steer clear’ of undermining polio vaccine, McConnell says

Senate Republican leader Mitch McConnell, a childhood polio survivor, said any of President-elect Donald Trump’s nominees seeking confirmation should “steer clear” of efforts to discredit the polio vaccine

The Independent UK

Sold-out farm shops, smuggled deliveries and safety warnings: US battle over raw milk grows

Unpasteurised milk, seen as both anti-government and anti-corporate, soars in popularity among conspiracy theorists and new agers

The Guardian - UK

Kratom is a "blessing and a curse"

For some, this supplement has replaced many medications including for substance use disorder

Salon

GRAIL: Biotech Stock Targeting $100B Cancer Market

GRAIL is a small biotech stock on the rise big time recently. Its innovative technology gives it the opportunity to capitalize on a massive addressable market.

MarketBeat

McConnell warns RFK Jr. over polio vax

The Senate minority leader threatened Kennedy's nomination over ties to a polio vaccine-targeting lawyer

Salon

Lawyer Petitions FDA To Revoke Polio Vaccine Approval

A lawyer linked to Trump's HHS nominee files petition to revoke polio vaccine approval, raising concerns about vaccine safety.

Top News

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

RFK Jr. adviser Aaron Siri petitioned the FDA to nix the polio vaccine. Here’s how immunization prevents the deadly disease

The polio vaccine has all but obliterated the illness that once killed thousands and paralyzed 15,000 people nationwide every year.

The Independent UK

Lawyer helping RFK Jr. vet health officials has asked the FDA to get rid of the polio vaccine

Kennedy has a history of questioning the efficacy of vaccines and elevating vaccine-related conspiracy theories

Fortune

The lawyer who is helping RFK Jr. pick officials for the Trump administration wants the FDA to revoke approval for the polio vaccine

Aaron Siri is interviewing and helping choose candidates for high-level health roles, according to the New York Times.

Fortune

These 6 common household products may be making Americans sick, a toxicologist warns

Some chemicals in household products can become harmful at certain levels and after repeated exposure.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - US

RFK Jr key adviser petitioned regulators to revoke approval of polio vaccine

Aaron Siri is helping Trump’s health secretary pick to select top jobs despite long history of attacking vaccines

The Independent UK

Trump provides update on Melania’s plans during his next term in wide-ranging Time interview

Last month insiders said that it was unlikely the former first lady would return to the White House for Trump’s second term

MarketBeat

2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead

Medtronic (MDT) and Zimmer Biomet (ZBH) are emerging as serious contenders in robotic surgery, challenging Intuitive Surgical’s (ISRG) market dominance.

Roll Call

Senate Democrats search for common ground with Kennedy - Roll Call

Some Senate Democrats are offering tentative support to Robert F. Kennedy Jr.’s advocacy for better nutrition and health.

MarketBeat

4 Stocks That Crushed Analyst Estimates by More Than Double

Hims & Hers, Alcoa, Vicor, and Stride crushed earnings with massive EPS beats. See what’s driving their growth and future potential.

Evening Standard

Starmer sends letter of praise to civil servants after ‘managed decline’ remarks

The Prime Minister said the Civil Service was ‘admired across the world’ after a backlash to his comments last week.

Investors Business Daily

UniQure Stock Doubles After Striking A Deal With The FDA For Huntington's Drug

UniQure stock doubled Tuesday after the company reached a testing agreement with the FDA for its Huntington's disease treatment.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.